Season 2

Join me with pharmacist, Michael Shuman, PharmD, for our next series on DTCA and Marketing of Healthcare. DTCA stands for Direct-To-Consumer-Advertising, of medications and diagnoses, to the American public. Our stance is this has had a tremendously negative impact on the quality of American healthc...

Here, I introduce my guest for this series, pharmacist Michael Shuman, PharmD. Michael has worked in several different areas of psychiatric pharmacy, including in multiple inpatient and outpatient settings. He currently works in the inpatient state hospital system and provides tremendous patient car...

Here, we reveal some of the actual clinical trial data about Aducanumab and Lecanamab, two Alzheimer's drugs that lowered the bar of FDA approval to an all-time low, revealing an absolute disregard for safety and efficacy of novel drugs and their potential negative impact on the American public.

We discuss the historical transition from before DTCA to its emergence in the 1980s, and subsequent legislation that allowed it to flourish in the mid-to-late 1990s.

In this segment, we discuss what DTCA is, different types of pharmaceutical ads, and the role of marketing in the American, and New Zealand's, healthcare system, the only two countries in the world where DTCA of pharmaceutical products is legal.

Our rant from this series is about the drug Vioxx's scandal from the early 2000s, a drug that has been implicated as contributing to hundreds of thousands of deaths and disabilities, and one in which Merck prioritized profits over Americans' health outcomes.

Here, we discuss some possible solutions to the problems posed by DTCA and marketing of healthcare, outside of the obvious solution of banning DTCA, which we don't have much faith will happen anytime soon in the United States.

Join Michael and I for our closing thoughts on the subject of DTCA and Marketing in Healthcare and stick around after for a listen to a local Louisville artist, Jack Rabbit and the Dirty Hares, with their song, 'Wyoming.'

Join us to discuss some pertinent examples of bad research and problems with the FDA Approval process, especially in mental health and with psychiatric medications.

These are a few segments pieced together that talk about Sexual Side Effects of psychiatric medications. We reveal a company that has tried to hijack and market one of the major side effects of SSRI antidepressants as a treatment for premature ejaculation, at the expense of potentially numbing sexua...

Here, Michael gives us a little bit of insight into his personal life and hobbies.

This is a teaser for the release of our next series on Lithium with Dr. Rifaat El-Mallakh. I'll try to include these at the end of each series so listeners know what's to come. Thanks for listening. For more social media content, check us out on all social media platforms @Renegadepsych. If you have...